Episode 62
Biotech Hangout
00:00
The Future of Biotech in China
I want to mention that Sam Fazelli from Bloomberg, Bloomberg Intelligence, who's a co-host of the show at times is, was in the audience and has come up. Yeah, I also think that once we start seeing some of these smaller deals, you know, the one, one to two billion dollar deals, those will also be helpful when we see those pick up. And then lastly, there were two, the, the, the trials that he thought were the, were the standouts and they were the ADCs. But I mean, let's not forget a lot of therapies moving early.
Transcript
Play full episode
